Expression of Human Papilloma Virus Infection, Proliferating Cell Nuclear Antigen and P53 in Cervical Squamous Cell Carcinoma

doi:10.3877/cma.j.issn.1673-5250.2011.02.017

Objective

To explore the expression of human papilloma virus (HPV)infection, proliferating cell nuclear antigen (PCNA) and P53 immunoreactions in cervical squamous cell carcinoma (SCC) and their possible correlation with the carcinoma occurrence and development.

Methods

From October 2005 to November 2009, clinical data of 35 cervical squamous cell carcinoma cases(SCC group) and 13 cervical erosion cases (cervical erosion group) were reviewed and compared with their immune-pathological data of human papilloma virus infection and/or proliferating cell nuclear antigen and/or P53 expressions. This study was detected by immunohistochemistry SP methods in the carcinoma tissues. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Centre for Nuclear Industry 416 Hospital. Informed consent was obtained from all participants.

Results

The positive immunoreactive rates of human papilloma virus infection, proliferating cell nuclear antigen and P53 in SCC group were significantly higher than those of cervical erosion group (P<0.05). The strongest proliferating cell nuclear antigen expression was associated with the lower differentiation of pathological grades (P<0.05), but human papilloma virus infection and P53 were not related to the tumor grades.

Conclusion

Human papilloma virus infection and P53 may play important roles in the pathogenesis of cervical squamous cell carcinoma. The over expression of proliferating cell nuclear antigen may indicate the worse carcinoma pathological grades, that may help to predict the prognosis for cervical squamous cell carcinoma patients.

Key words: human papilloma virus (HPV) infection, proliferating cell nuclear antigen (PCNA), P53, cervical squamous cell carcinoma

	1　Montoya-Fuentes H, Suárez Rincón AE, Ramírez-Muñoz MP, et al. The detection of human papillomavirus16，18, 35 and 58 in cervical-uterine cancer and advanced degree of squamous intraepithelial lesion in western.Mexico: Clinical-molecular correlation[J]．Gynecol Obstet Mex, 2001, 69: 137-142.
	2　Zur HH. Cervical cancer-papillomavirus and P53[J]. Nature, 1998, 393: 217.
	3　Jorge O, Cuello Carrión FD, Jorge A, et al. Helicobacter pylori infection affects the expression of PCNA, p53, c-erb B-2 and Bcl-2 in the human gastric mucosa [J]．Rev Esp Enferm Dig, 2003, 95(2): 97-104.

[1]	Wenfeng Ma, Hui Zhang, Naijun Fan, Fulin Li, Nianlong Meng, Xutao Yuan, Changsong Wang. Expression of apoptosis-stimulating protein of p53 family members in invasive breast cancer and its prognostic significance[J]. Chinese Journal of Breast Disease(Electronic Edition), 2020, 14(01): 44-49.
[2]	Chao Gao, Chen Zheng, Xin Huang, Wanlin Li. Expression and clinical significance of HOXA10 and P53 in colorectal cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(01): 40-44.
[3]	Yan Wang, Luo Zhang, Zaiyong Pan. Relationship of P53 protein expression with preoperative concurrent chemoradiotherapy sensitivity for rectal cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(02): 111-115.
[4]	Zhen Lei, Zhenghui Guo, Chen Tang, Shengmeng Peng, Yanting Ren, Wanhua Wu, Jie Zhou, Yongming Chen, Lingfeng Li, Hai Huang, Yiming Lai. ASF1B enhances the migration and proliferation of prostate cancers via regulating p53-related signaling pathways[J]. Chinese Journal of Endourology(Electronic Edition), 2022, 16(03): 262-269.
[5]	Zheng Li, Meng Zhao, Peng Ge, Aimin Zhang, Li Ren. Overexpression of LNCRNA 00593 regulates cisplatin resistance in non-small cell lung cancer through the p53 pathway[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2020, 13(06): 724-730.
[6]	Yuan Zhou, Jing Dong, Yaxi Chen, Yang Xie, LingHong Ning. P53-induced nuclear protein 2 promotes invasion and metastasis of breast cancer cells through activating β-catenin[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2021, 11(05): 262-271.
[7]	Zhou Yang, Linsen Ye, Xiao Feng, Yunliang Xie, Xiaobin Li, Binsheng Fu. Bioinformatics analysis of TP53 expression in hepatocellular carcinoma and its effect on clinical prognosis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(01): 87-91.
[8]	Huiling Zhang, Jiaojiao Gu, Siyuan Hong, Xiaolan Lin. Effect of TRIM8 gene on proliferation and invasion of hepatocellular carcinoma cells and its mechanism[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(05): 458-462.
[9]	Zechao Zhu, Xinyu Yang, Youcheng Li, Pengyu Pan, Guobiao Liang. Impact of genistein on early brain injury following subarachnoid hemorrhage in mice via the SIRT1/p53 signaling pathway[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(05): 261-269.
[10]	Qiqi Jiang, Yikuan Feng, Kai Zhang, Qian Li, Wansheng Ji. Role of Δ133p53 in the growth of human gastric cancer cell MKN-45 transplanted tumor[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2021, 11(05): 215-219.
[11]	Qiaoqiao Huang, Junying Chen, Jinbing Huang, Wensheng Xu, Erling Chen. Analysis of relationship between RAS pathway related genes and cervical cancer metastasis using bioinformatics methods[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(02): 112-123.
[12]	Fang Li, Yueping Liu, Mengxue Han, Guiying Wang. Identification of independent prognostic factors for colon cancer based on p53 protein expression and tumor budding histology[J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(11): 890-896.
[13]	Min Lin, Lu Song, Shuming Qin, Gang Hou. Five cases of gliosarcoma: clinicopathological analysis and a literature review[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(06): 473-477.
[14]	Fengcheng Hao, Guoliang Li, Yazhou Wang, Debiao Liu, Xuan Zhou, Yan Liu. An evidence-based analysis of P53 and the prognosis of radical resection of esophageal squamous cell carcinoma[J]. Chinese Journal of Diagnostics(Electronic Edition), 2020, 08(03): 208-216.
[15]	Meng Bian, Qingqing Feng, Xiao Luo, Yufeng Du. Expression and significance of LncRNA CDKN2B-AS1/CDKN2A and p53 in idiopathic pulmonary fibrosis and lung cancer in mice[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2021, 08(02): 10-16.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export